BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25175498)

  • 21. Redox regulation of FoxO transcription factors.
    Klotz LO; Sánchez-Ramos C; Prieto-Arroyo I; Urbánek P; Steinbrenner H; Monsalve M
    Redox Biol; 2015 Dec; 6():51-72. PubMed ID: 26184557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia.
    Liu LL; Zhang DH; Mao X; Zhang XH; Zhang B
    Biochem Biophys Res Commun; 2014 Mar; 446(1):280-5. PubMed ID: 24582753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Regulation of Stem Cells and Differentiation: A Forkhead Box O Transcription Factor Perspective.
    Ludikhuize MC; Rodríguez Colman MJ
    Antioxid Redox Signal; 2021 May; 34(13):1004-1024. PubMed ID: 32847377
    [No Abstract]   [Full Text] [Related]  

  • 24. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The discrete roles of individual FOXO transcription factor family members in B-cell malignancies.
    Lees J; Hay J; Moles MW; Michie AM
    Front Immunol; 2023; 14():1179101. PubMed ID: 37275916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
    Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
    Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new fork for clinical application: targeting forkhead transcription factors in cancer.
    Yang JY; Hung MC
    Clin Cancer Res; 2009 Feb; 15(3):752-7. PubMed ID: 19188143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FoxM1 as a novel therapeutic target for cancer drug therapy.
    Xu XS; Miao RC; Wan Y; Zhang LQ; Qu K; Liu C
    Asian Pac J Cancer Prev; 2015; 16(1):23-9. PubMed ID: 25640357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deciphering the role of forkhead transcription factors in cancer therapy.
    Yang JY; Hung MC
    Curr Drug Targets; 2011 Aug; 12(9):1284-90. PubMed ID: 21443462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXO and FOXM1 in cancer: the FOXO-FOXM1 axis shapes the outcome of cancer chemotherapy.
    Wilson MS; Brosens JJ; Schwenen HD; Lam EW
    Curr Drug Targets; 2011 Aug; 12(9):1256-66. PubMed ID: 21443467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance.
    Nestal de Moraes G; Bella L; Zona S; Burton MJ; Lam EW
    Curr Drug Targets; 2016; 17(2):164-77. PubMed ID: 25418858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia.
    Wang JY; Jia XH; Xing HY; Li YJ; Fan WW; Li N; Xie SY
    Mol Med Rep; 2015 Jul; 12(1):1457-64. PubMed ID: 25760224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Roles of FoxO Transcription Factors in Regulation of Bone Cells Function.
    Ma X; Su P; Yin C; Lin X; Wang X; Gao Y; Patil S; War AR; Qadir A; Tian Y; Qian A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
    Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
    Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOX(M1) news--it is cancer.
    Halasi M; Gartel AL
    Mol Cancer Ther; 2013 Mar; 12(3):245-54. PubMed ID: 23443798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors.
    Wang IC; Meliton L; Tretiakova M; Costa RH; Kalinichenko VV; Kalin TV
    Oncogene; 2008 Jul; 27(30):4137-49. PubMed ID: 18345025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of Her-2 upregulates FoxM1 in gastric cancer.
    Qi W; Li X; Zhang Y; Yao R; Qiu W; Tang D; Liang J
    Int J Mol Med; 2014 Jun; 33(6):1531-8. PubMed ID: 24715000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central venous hypoxemia is a determinant of human atrial ATP-sensitive potassium channel expression: evidence for a novel hypoxia-inducible factor 1alpha-Forkhead box class O signaling pathway.
    Raeis V; Philip-Couderc P; Roatti A; Habre W; Sierra J; Kalangos A; Beghetti M; Baertschi AJ
    Hypertension; 2010 May; 55(5):1186-92. PubMed ID: 20212266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.